Registered Nurse in Simsbury, CT Accepting Medicare
2 Registered Nurse nurses found. Showing 1 - 2
 Kori Kollanda, RN, IBCLC Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 90 Plank Hill Rd, Simsbury, CT 06070 Phone: 860-909-8008 |
Mrs. Roxanne Sudhoff, RN, IPC Registered Nurse - Infection Control Medicare: Not Enrolled in Medicare Practice Location: 36 Firetown Rd, Simsbury, CT 06070 Phone: 860-658-1018 Fax: 860-658-7250 |
News Archive
Children may consume more titanium dioxide than adults
Children may be receiving the highest exposure to nanoparticles of titanium dioxide in candy, which they eat in amounts much larger than adults, according to a new study. Published in ACS' journal, Environmental Science & Technology, it provides the first broadly based information on amounts of the nanomaterial - a source of concern with regard to its potential health and environmental effects - in a wide range of consumer goods.
PUFA levels reduced in schizophrenia patients
Patients with schizophrenia exhibit reduced red blood cell levels of certain polyunsaturated fatty acids , results from a systematic review and meta-analysis show.
‘Last responders' seek to expand postmortem COVID testing in unexplained deaths
Examining dead bodies and probing for a cause of death is rarely seen as a heroic or glamorous job. Rather, as the coronavirus pandemic has unfolded, all eyes have been on the medical workers and public health disease detectives fighting on the front lines - and sometimes giving their lives — to bring the novel coronavirus under control.
An overview of spike protein antigen COVID-19 vaccine candidates
A new paper in the journal Reviews in Medical Virology provides a perspective on current vaccine development strategies and tools, which may allow the production of safe and effective vaccines.
Multiple studies examine ideal biomarkers for Huntington's disease
While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends upon the identification of reliable and sensitive biomarkers to track disease and evaluate therapies, and these biomarkers may eventually be used as outcome measures in clinical trials. Biomarkers could be especially helpful to monitor changes during the time prior to diagnosis and appearance of overt symptomatology.
› Verified 5 days ago